Furthermore, PBLs from patients with MPC showed a greater proportion of CD4+CD25+FOXP3+ Tregs, exhausted CD8+CTLA4+ T cells, CD8+CD122+ T cells, and CD8+CD45R+ T cells, which can be regarded as tumor-promoting cells, than in patients with BPC. This evidence concerns the gene CTLA4 and neoplasm.